Table 1. Details of all identified QTL.
Trait | Gene location | Treatment | Peak location | BCI | −log10(P-value) |
---|---|---|---|---|---|
Mipp2 | X: 6.08 | DR | X: 5.94 | 5.93–6.25 | 24.4 |
Mipp2 | X: 6.08 | C | X: 6.15 | 5.91–5.95 | 16.1 |
Mipp2 | X: 6.08 | HS | X: 5.94 | 5.91–6.24 | 29.9 |
dsh | X: 11.35 | DR | X: 11.36 | 11.30–11.39 | 13.73 |
dsh | X: 11.35 | C | X: 11.34 | 11.31–11.36 | 24.04 |
dsh | X: 11.35 | HS | X: 11.34 | 11.28–11.36 | 19.53 |
Pi3K21B | 2L: 0.30 | C | 2L: 0.75 | 0.07–0.94 | 4.80 |
Pi3K21B | 2L: 0.30 | HS | 2L: 0.55 | 0.27–0.93 | 5.70 |
Lip4 | 2L: 10.53 | C | 2L: 10.28 | 10.25–10.71 | 4.49a |
hppy | 2R: 19.18 | C | 2R: 19.14 | 18.54–19.54 | 6.90 |
hppy | 2R: 19.18 | HS | 2R: 19.19 | 18.90–20.22 | 4.65 |
stepb | 2L: 21.74 | DR | X: 15.42 | 15.39–15.47 | 5.76a |
PRAS40 | 2R: 14.48 | C | 2R: 14.15 | 13.98–14.78 | 4.53a |
PRAS40 | 2R: 14.48 | HS | 2R: 14.36 | 14.27–14.61 | 4.20a |
Pi3K59F | 2R: 23.56 | DR | 2R: 23.55 | 23.49–23.74 | 6.73 |
Pi3K59F | 2R: 23.56 | C | 2R: 23.64 | 23.56–23.68 | 11.28 |
Pi3K59F | 2R: 23.56 | HS | 2R: 23.54 | 23.47–23.60 | 10.79 |
Ilp5b | 3L: 9.82 | DR | X: 22.91 | 22.60–22.98 | 5.47a |
slif | 3L: 22.88 | DR | 3L: 20.98 | 3L 20.93–3R 3.46 | 4.74a |
REPTOR | 3R: 24.56 | DR | 3R: 24.67 | 24.25–24.74 | 5.49 |
REPTOR | 3R: 24.56 | C | 3R: 24.66 | 24.32–24.76 | 7.77 |
REPTOR | 3R: 24.56 | HS | 3R: 24.60 | 24.46– 24.67 | 7.83 |
Linear discriminant | — | DR | 2R: 9.41 | 6.12–9.63 | 5.96 |
Linear discriminant | — | DR vs. C | 2R: 7.76 | 7.71–9.47 | 5.43c |
Median life span | — | DR vs. C | 3R: 9.34 | 3L 17.35–3R 10.74 | 3.89c |
Median life span | — | DR | 3L: 3.65 | 3.23–3.84 | 3.68c |
trans-eQTL (i.e., peaks at locations distant from gene location).
FDR = 10%.
FDR = 33%.